Drug Shortage Report for VOLTAREN
Report ID | 123884 |
Drug Identification Number | 00632724 |
Brand name | VOLTAREN |
Common or Proper name | VOLTAREN 50 MG SUPP (5X6) |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 50MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | 5 X 6 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-09-04 |
Actual start date | 2020-09-02 |
Estimated end date | 2020-10-16 |
Actual end date | 2020-10-16 |
Shortage status | Resolved |
Updated date | 2020-10-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-08 | English | Compare |
v2 | 2020-09-08 | French | Compare |
v3 | 2020-09-14 | English | Compare |
v4 | 2020-09-14 | French | Compare |
v5 | 2020-10-19 | English | Compare |
v6 | 2020-10-19 | French | Compare |
Showing 1 to 6 of 6